Ivermectin for COVID-19
4th treatment shown to reduce risk in
August 2020, now with p < 0.0000000001 from 106 studies, recognized in 24 countries.
No treatment is 100% effective.
Protocols combine treatments.
Discussion of Merck's ivermectin statements and past actions related to Vioxx raising significant concerns.
Scheim et al., 7 Sep 2021, preprint, 1 author.